comprehensive -WSS

comprehensive

author：entertainment 2025-09-28 23:48:15 - browse：3568

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter:

The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, Sarepta Therapeutics. Confirming the gene therapy’s benefit — and potentially broadening its use to include older boys — will be determined by a Phase 3 clinical trial that will read out later this quarter.

Pfizeris developing its own gene therapy for Duchenne in a fully enrolled Phase 3 study with final results expected in 2024. But before the verdict is revealed, Pfizer intends to conduct an interim analysis later this quarter. The most likely outcome of this early look will be a determination to continue the study to its completion. But surprises — including an early stop for overwhelming efficacy — can’t be ruled out.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Stanford president to resign after investigation of research

leisure time

entertainment

WSS

Testing for cancer recurrence creates a new limbo for patients

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

The FDA weighs the risks of candy

Telehealth options flood the market as retailers push virtual care

entertainment

comprehensive

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

First Opinion Podcast: How to protect health care in times of war

DIEP, the 'gold standard' of breast reconstruction, is under threat

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Anesthesiologist group: stop taking Ozempic before surgery

India sets sights on home

Walensky prepares to leave CDC — and Congress — behind

The pink breast cancer awareness ribbon needs a redesign

Anesthesiologist group: stop taking Ozempic before surgery

Researchers separate signal from noise in heart wearable data

knowledge

States increasingly look to regulate hospital facility fees

First Opinion Podcast: How to protect health care in times of war

Plane’s emergency slide plummets from sky, hits Chicago home

Why the Crimean Bridge is key to Russia's war in Ukraine

Telehealth options flood the market as retailers push virtual care

The pink breast cancer awareness ribbon needs a redesign

leisure time

entertainment

explore

knowledge